Abvc Biopharma Stock Analysis

ABVC
 Stock
  

USD 0.91  0.10  12.35%   

The modest gains experienced by current holders of Abvc Biopharma could raise concerns from investors as the firm is trading at a share price of 0.91 on 97,000 in volume. The company management teams have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in August. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.24. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Abvc Biopharma partners.
Please continue to Trending Equities.
  
The Abvc Biopharma stock analysis report makes it easy to digest most publicly released information about Abvc Biopharma and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Abvc Biopharma Stock analysis module also helps to analyze the Abvc Biopharma price relationship with some important fundamental indicators such as market cap and management efficiency.

Abvc Biopharma Stock Analysis Notes

About 41.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.5. Abvc Biopharma had not issued any dividends in recent years. The entity had a split on the 8th of May 2019. ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people. For more info on Abvc Biopharma please contact the company at 510 668 0881 or go to https://www.abvcpharma.com.

Abvc Biopharma Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Abvc Biopharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Abvc Biopharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Abvc Biopharma has very high historical volatility over the last 90 days
Abvc Biopharma has some characteristics of a very speculative penny stock
The company reported the previous year's revenue of 118.31 K. Net Loss for the year was (17.71 M) with profit before overhead, payroll, taxes, and interest of 350.71 K.
Abvc Biopharma currently holds about 2.81 M in cash with (9.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Roughly 41.0% of the company shares are held by company insiders
Latest headline from www.tipranks.com: ABVC BioPharma in Focus on ADHD Trial Update - TipRanks

Abvc Biopharma Upcoming and Recent Events

Earnings reports are used by Abvc Biopharma to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Abvc Biopharma previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report16th of November 2021
Next Fiscal Quarter End30th of September 2021
Last Quarter Report30th of June 2021
Last Financial Announcement30th of September 2020

Abvc Biopharma SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Abvc Biopharma prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Abvc Biopharma investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Abvc Biopharma specific information freely available to individual and institutional investors to make a timely investment decision.
13th of September 2022
Financial Statements and Exhibits. Other Events
View
9th of September 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
22nd of August 2022
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
View
14th of July 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
12th of July 2022
Unclassified Corporate Event
View
21st of June 2022
Financial Statements and Exhibits. Other Events. Entry into a Material Definitive Agreement
View
9th of June 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
1st of June 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View

Abvc Biopharma Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Abvc Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Abvc Biopharma backward and forwards among themselves. Abvc Biopharma's institutional investor refers to the entity that pools money to purchase Abvc Biopharma's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Armistice Capital LlcCommon Shares1.1 M1.2 M
Vanguard Group IncCommon Shares375.1 K398 K
Geode Capital Management LlcCommon Shares49.9 K52 K
Blackrock IncCommon Shares39 K41 K
Tower Research Capital Llc TrcCommon SharesKK
Concourse Financial Group Securities IncCommon Shares0.00.0
Vanguard Group IncCommon Shares375.1 KM
Note, although Abvc Biopharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Abvc Biopharma Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 21.46 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abvc Biopharma's market, we take the total number of its shares issued and multiply it by Abvc Biopharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (92.24) % which means that it has lost $92.24 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (372.46) %, meaning that it created substantial loss on money invested by shareholders. Abvc Biopharma management efficiency ratios could be used to measure how well abvc biopharma manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 26th of September, Abvc Biopharma shows the Risk Adjusted Performance of 0.0469, mean deviation of 5.04, and Downside Deviation of 7.36. Abvc Biopharma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to interpolate and analyze data for nineteen technical drivers for Abvc Biopharma, which can be compared to its rivals. Please confirm Abvc Biopharma treynor ratio, as well as the relationship between the potential upside and expected short fall to decide if Abvc Biopharma is priced correctly, providing market reflects its regular price of 0.91 per share. Given that Abvc Biopharma is a hitting penny stock territory we recommend to closely look at its total risk alpha.

Abvc Biopharma Price Movement Analysis

The output start index for this execution was eight with a total number of output elements of fifty-three. The Moving Average is predictive technique used to analyze Abvc Biopharma price data points by creating a series of averages of different subsets of Abvc Biopharma entire price series.
.

Abvc Biopharma Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Abvc Biopharma insiders, such as employees or executives, is commonly permitted as long as it does not rely on Abvc Biopharma's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Abvc Biopharma insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Jiang Shuling over two months ago via Macroaxis 
Abvc Biopharma exotic insider transaction detected
An Chihliang over three months ago via Macroaxis 
Abvc Biopharma exotic insider transaction detected
Odaira Yoshinobu over six months ago via Macroaxis 
Abvc Biopharma exotic insider transaction detected
Miao Shinyu over six months ago via Macroaxis 
Abvc Biopharma exotic insider transaction detected
Jiang Tsang Ming over six months ago via Macroaxis 
Abvc Biopharma exotic insider transaction detected

Abvc Biopharma Predictive Daily Indicators

Abvc Biopharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abvc Biopharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Abvc Biopharma Forecast Models

Abvc Biopharma time-series forecasting models is one of many Abvc Biopharma's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abvc Biopharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Abvc Biopharma Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Abvc Biopharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abvc Biopharma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual Stock such as Abvc Biopharma. By using and applying Abvc Biopharma Stock analysis, traders can create a robust methodology for identifying Abvc Biopharma entry and exit points for their positions.
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation. Abvc Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 28 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Abvc Biopharma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module
Please continue to Trending Equities. You can also try Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for analysis

When running Abvc Biopharma price analysis, check to measure Abvc Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abvc Biopharma is operating at the current time. Most of Abvc Biopharma's value examination focuses on studying past and present price action to predict the probability of Abvc Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abvc Biopharma's price. Additionally, you may evaluate how the addition of Abvc Biopharma to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Is Abvc Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abvc Biopharma. If investors know Abvc Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abvc Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Abvc Biopharma is measured differently than its book value, which is the value of Abvc Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of Abvc Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Abvc Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abvc Biopharma's market value can be influenced by many factors that don't directly affect Abvc Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abvc Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Abvc Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abvc Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.